Yann Touchefeu

Centre National de la Recherche Scientifique

Also affiliated with Inserm, Hotel Dieu Hospital, Centre Hospitalier Universitaire de Nantes, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, Institut Génétique Nantes Atlantique, Centre d'Investigation Clinique de Nantes, Nantes Université

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A

0Author DataRank · unranked

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer”.

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

JAMA Oncology(2022)10.1001/jamaoncol.2022.3829

N/A

9.5DataRank · unranked

335 citations

Florence Castan, Anthony Lopez, Anthony Turpin, Meher Ben Abdelghani, Alice C. Wei +87 more

Mixed neuroendocrine non-neuroendocrine neoplasm combining neuroendocrine tumor with hepatocellular carcinoma in the context of multiple endocrine neoplasia type 1

Clinics and Research in Hepatology and Gastroenterology(2025)10.1016/j.clinre.2025.102533

N/A

0.165DataRank · unranked

2 citations

Jean-François Mosnier, Eric Frampas, Tamara Matysiak-Budnik, Bastien Jamet, Yann Touchefeu +1 more